title: Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis: the authors respond.
authors: Medical Technology and Practice Patterns Institute, Bethesda, Maryland 20814, USA.
authors: Mae
authors: M
authors: Thamer
authors: Yi
authors: Y
authors: Zhang
authors: James
authors: J
authors: Kaufman
authors: Dennis
authors: D
authors: Cotter
authors: Miguel A
authors: MA
authors: Hernán
mesh_terms: D003153:Community Health Services / Q000191:economics* / Q000379:methods; D004305:Dose-Response Relationship, Drug; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000191:economics*; D006397:Hematinics / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D010067:Ownership / Q000191:economics*; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000191:economics* / Q000379:methods
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa